Home » Lifestyle » FDA says it's 'working to address' shortage of albuterol product used in hospitals
FDA says it's 'working to address' shortage of albuterol product used in hospitals
FOX Business Flash top headlines for March 9
Check out what’s clicking on FoxBusiness.com
There is a scarcity of a certain albuterol medication product – and the Food and Drug Administration (FDA) said Wednesday night that it is "working to address" that.
According to the FDA, the shortage is only for a "very specific dosage form of the medication generally used in hospitals." On its website, the agency reported as "not available" the particular dosage of the albuterol sulfate inhalation solution and indicated the supply issue dates back to October.
Medical professionals utilize albuterol – a drug that comes in different varieties – for bronchospasm treatment, according to the Mayo Clinic.
DRUG SHORTAGE SWELLS TO NATIONAL EMERGENCY, FORCING DOCTORS TO FIND NEW WAYS TO TREAT PATIENTS
There is a sufficient amount of other "strengths and vial sizes" to "meet market demand at hospitals and beyond" at this time, the FDA said. The agency also emphasized that in the case of this particular shortage, albuterol inhalers are not affected.
In connection to shortage-related impacts, the FDA has been "working closely" with manufacturers and others, according to the agency’s tweet.